Life science News and Research

RSS

Gladstone investigator wins MIND Prize to decode hidden Alzheimer’s genetics

Gladstone Institutes investigator Ryan Corces, PhD, has been named a 2026 winner of the Pershing Square Foundation's MIND Prize, a prestigious award recognizing next-frontier thinkers who are uncovering a deeper understanding of the brain and cognition.

7 Apr 2026

First participants join clinical study to fast-track dementia research in the UK

The Dementia Trials Accelerator has taken a significant step towards transforming dementia clinical trials in the UK by welcoming its first participants into clinics for simple tests that will ultimately get the right people into clinical trials quicker, speeding up vital research.

7 Apr 2026

Researchers uncover a chain of molecular events behind early brain changes in Alzheimer's

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin changing long before any memory problems appear.

3 Apr 2026

Where digital holographic microscopy complements fluorescence microscopy

Integrating Digital Holographic Microscopy with fluorescence techniques enhances live-cell imaging, preserving cellular integrity and improving assay accuracy.

From Park Systems 2 Apr 2026

New therapy reprograms immune cells to reduce asthma inflammation

A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and Shenzhen University School of Medicine has provided the first proof-of-principle study demonstrating that targeting a receptor on the surface of anti-inflammatory regulatory T cells (Tregs) can restore their function and alleviate asthma in mice.

31 Mar 2026

Semarion secures $3.8 million to scale next-generation cell assay technology and accelerate pharma adoption

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).

From Semarion 31 Mar 2026

Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis

Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its strategic repositioning.

From Broken String Biosciences 31 Mar 2026

ATLAS platform enables realistic study of metastatic cancer clusters

Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part because researchers lack reliable ways to recreate the conditions cancer cells encounter as they travel through the bloodstream.

26 Mar 2026

New Legionella testing selective agar plates launched by AnalytiChem

AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has launched a new addition to its high-quality Redipor® microbiological prepared media portfolio.

From AnalytiChem 24 Mar 2026

New computational method links individual cells to patient outcomes

A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data.

23 Mar 2026

Researchers explore "block and lock" strategy for functional HIV cure

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs-commonly referred to as antiretroviral therapy-the virus usually rushes back within weeks.

23 Mar 2026

Expanded access to rotational atherectomy maintains safety in PCI procedures

Percutaneous coronary intervention (PCI) is a standard treatment for significant coronary artery disease. Cardiologists use a catheter to place a stent that opens up the blockage and restores blood flow to the heart.

19 Mar 2026

Muscle-repairing macrophages trigger heterotopic ossification in mice

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ossificans progressiva (FOP), Mrep functions as a pathogenic cell that triggers heterotopic ossification.

18 Mar 2026

Sartorius launches next-generation platform to boost efficiency in cell therapy production

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

From Sartorius 18 Mar 2026

Bedfont® Scientific Limited strengthens its position as world leaders in breath analysis with a new board member

Bedfont® Scientific Ltd., a world leader in breath analysis, has been designing and manufacturing medical breath analysis devices for almost 50 years and has seen significant growth over the past decade.

From Bedfont® Scientific Ltd 17 Mar 2026

Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

Lab Thread Ltd, a UK-based life science software company, today announced the release of a free of charge version of the Company's Unified Lab Software Platform, available to academic and non-profit researchers worldwide.

From Lab Thread 16 Mar 2026

Alexandra Knauer receives the Pittcon Heritage Award

Entrepreneur Alexandra Knauer, managing director of lab instrument manufacturer KNAUER, is honored in the USA with the Pittcon Heritage Award 2026.

From KNAUER Wissenschaftliche Geräte GmbH 10 Mar 2026

Eppendorf introduces SpinPro® centrifuge series to streamline life science research

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the commercial launch of the SpinPro® 6 R centrifuge, the first in the Company's new range of SpinPro floor-standing and benchtop centrifuges.

9 Mar 2026

Abselion establishes US subsidiary in Cambridge, MA

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA.